These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 16118830)

  • 21. Divalproex sodium in alcohol withdrawal: a randomized double-blind placebo-controlled clinical trial.
    Reoux JP; Saxon AJ; Malte CA; Baer JS; Sloan KL
    Alcohol Clin Exp Res; 2001 Sep; 25(9):1324-9. PubMed ID: 11584152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
    Tourian KA; Padmanabhan SK; Groark J; Brisard C; Farrington D
    Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recognition and treatment of the alcohol withdrawal syndrome.
    Leroy JB
    Prim Care; 1979 Sep; 6(3):529-39. PubMed ID: 392576
    [No Abstract]   [Full Text] [Related]  

  • 25. Safety of ipsapirone treatment compared with lorazepam: discontinuation effects.
    Busto UE; Naranjo CA; Bremner KE; Peachey JE; Bologa M
    J Psychiatry Neurosci; 1998 Jan; 23(1):35-44. PubMed ID: 9505058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quetiapine decreases alcohol consumption, craving, and psychiatric symptoms in dually diagnosed alcoholics.
    Martinotti G; Andreoli S; Di Nicola M; Di Giannantonio M; Sarchiapone M; Janiri L
    Hum Psychopharmacol; 2008 Jul; 23(5):417-24. PubMed ID: 18425995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antipsychotic efficacy of the antidepressant trimipramine: a randomized, double-blind comparison with the phenothiazine perazine.
    Bender S; Olbrich HM; Fischer W; Hornstein C; Schoene W; Falkai P; Haarmann C; Berger M; Gastpar M;
    Pharmacopsychiatry; 2003; 36(2):61-9. PubMed ID: 12734763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multidimensionality of the Alcohol Withdrawal Symptom Checklist: a factor analysis of the Alcohol Withdrawal Symptom Checklist and CIWA-Ar.
    Pittman B; Gueorguieva R; Krupitsky E; Rudenko AA; Flannery BA; Krystal JH
    Alcohol Clin Exp Res; 2007 Apr; 31(4):612-8. PubMed ID: 17374040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyamemazine decreases ethanol intake in rats and convulsions during ethanol withdrawal syndrome in mice.
    Naassila M; Legrand E; d'Alche-Birée F; Daoust M
    Psychopharmacology (Berl); 1998 Dec; 140(4):421-8. PubMed ID: 9888617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential role of cortical 5-HT(2A) receptors in the anxiolytic action of cyamemazine in benzodiazepine withdrawal.
    Benyamina A; Naassila M; Bourin M
    Psychiatry Res; 2012 Jul; 198(2):307-12. PubMed ID: 22421069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carbamazepine versus oxazepam in the treatment of alcohol withdrawal: a double-blind study.
    Stuppaeck CH; Pycha R; Miller C; Whitworth AB; Oberbauer H; Fleischhacker WW
    Alcohol Alcohol; 1992 Mar; 27(2):153-8. PubMed ID: 1524606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Zonisamide versus diazepam in the treatment of alcohol withdrawal syndrome.
    Rubio G; López-Muñoz F; Ponce G; Pascual JM; Martínez-Gras I; Ferre F; Jiménez-Arriero MÁ; Alamo C
    Pharmacopsychiatry; 2010 Nov; 43(7):257-62. PubMed ID: 20927698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.
    Naukkarinen H; Raassina R; Penttinen J; Ahokas A; Jokinen R; Koponen H; Lepola U; Kanerva H; Lehtonen L; Pohjalainen T; Partanen A; Mäki-Ikola O; Rouru J;
    Eur Neuropsychopharmacol; 2005 Dec; 15(6):617-23. PubMed ID: 15949921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenobarbital versus diazepam for delirium tremens--a retrospective study.
    Hjermø I; Anderson JE; Fink-Jensen A; Allerup P; Ulrichsen J
    Dan Med Bull; 2010 Aug; 57(8):A4169. PubMed ID: 20682133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends in the management of alcohol withdrawal syndrome.
    Newman JP; Terris DJ; Moore M
    Laryngoscope; 1995 Jan; 105(1):1-7. PubMed ID: 7837904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Double-blind comparison of ketazolam, diazepam and placebo in once-a-day vs t.i.d. dosing.
    Anhalt HS; Young R; Roginsky M
    J Clin Psychiatry; 1980 Nov; 41(11):386-92. PubMed ID: 6108319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A pilot double-blind treatment trial of memantine for alcohol dependence.
    Evans SM; Levin FR; Brooks DJ; Garawi F
    Alcohol Clin Exp Res; 2007 May; 31(5):775-82. PubMed ID: 17378918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multicenter, double-blind, controlled comparison of zolpidem and triazolam in elderly patients with insomnia.
    Roger M; Attali P; Coquelin JP
    Clin Ther; 1993; 15(1):127-36. PubMed ID: 8458042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
    Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME
    J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.